Wire Stories
451Nidec Announces Financial Results for Fiscal Third Quarter and Nine Months Ended December 31, 2023
KYOTO, Japan–(BUSINESS WIRE)–Nidec Corporation (TOKYO: 6594) (OTC US: NJDCY) today announced its consolidated financial results under the International Financial Reporting Standards (“IFRSâ€)...
- 539
Nidec Revises Consolidated Financial Forecasts and Year-End Dividend Projection for the Year Ending March 31, 2024
KYOTO, Japan–(BUSINESS WIRE)–Nidec Corporation (TOKYO:6594; OTC US: NJDCY) (the “Companyâ€) today announced a revision to its IFRS-based consolidated full-year financial forecasts and...
- 546
Smart Lander for Investigating Moon “SLIM” Touches Down on Moon
TOKYO–(BUSINESS WIRE)–Mitsubishi Electric Corporation (TOKYO:6503) announced today that its Smart Lander for Investigating Moon (SLIM), developed by the company under contract with...
- 471
BetterCommerce Fuels DaMENSCH Expansion Strategy with Composable Commerce
NEW DELHI–(BUSINESS WIRE)–#ecommerce–BetterCommerce, a leading end-to-end e-commerce technology provider, is proud to announce its partnership with DaMENSCH, a brand renowned for its...
- 430
SEKISUI CHEMICAL CO., LTD. and RevolKa Signed a Contract Research Agreement
RevolKa will create highly functional proteins by using AI-driven platform TOKYO–(BUSINESS WIRE)–RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering...
- 411
Rio Tinto Statement – Plane crash near Fort Smith, Northwest Territories, Canada
MELBOURNE, Australia–(BUSINESS WIRE)–We have been informed by authorities that a plane on its way to our Diavik mine, carrying a number of...
- 435
Best’s Commentary: AM Best Issues FAQ on Its Country Risk Evaluation of China Following Economic Slowdown
OLDWICK, N.J.–(BUSINESS WIRE)–#insurance—AM Best has issued a new commentary on its country risk evaluation process in response to recent concerns about China’s...
- 484
InnoCare Announces First Pediatric Patient Dosed in Clinical Trial of pan-TRK Inhibitor Zurletrectinib in China
BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today...
- 456
Asia Pacific Cloud Spend Rebounds in Q4, ISG Indexâ„¢ Finds
XaaS spending in Q4 up 10% vs. prior year, while managed services fell 34% ISG forecasts 15% XaaS revenue growth and 4.25%...
- 487
Clarius Dual-Array Wireless Handheld Scanner for Whole-Body Ultrasound Imaging Now Available in Australia
New Clarius PAL HD3 ultrasound scanner enables hospital physicians and nurses in urban and rural hospitals to quickly diagnose and guide treatment...
